2009-11-10 00:57:02 -
Med BioGene Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/med-biogene- ..
Med BioGene Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Med BioGene Inc. (MBI) is a developmental stage life sciences company which is focused on the development genomic biomarker based clinical laboratory tests for early diagnosis and screening for cancer and cardiovascular disease. the company´s lead product is LungExpress Dx, a test for early-stage non-small-cell lung cancer. It analyses
the genetic profile of the patient´s tumour cell to to assist in diagnosis and prognosis. The companys extensive laboratories & office are on the campus of the University of British Colombia. It is headquartered in Vancouver, Canada
The Med BioGene Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
